{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-170634","form_type":"8-K","ticker":"MDGL","cik":"0001157601","company_name":"MADRIGAL PHARMACEUTICALS, INC.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.475488+00:00","generated_at":"2026-06-01T00:56:43.743137+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Madrigal shareholders approve 750K share increase to stock plan, extend to 2035","bullets":["Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 750,000 shares.","Plan extended through 2035; clawback policy and one-year minimum vesting requirement added.","All three Class II director nominees (Sibold, Taub, Craves) elected with over 95% support.","PricewaterhouseCoopers ratified as independent auditor for FY2024 with 99.4% of votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-170634","json":"https://secwatch.observer/filing/0001193125-24-170634.json","markdown":"https://secwatch.observer/filing/0001193125-24-170634.md","text":"https://secwatch.observer/filing/0001193125-24-170634.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/0001193125-24-170634-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/d839852d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:56:43.743137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}